Form 8-K - Current report:
SEC Accession No. 0001193125-17-121519
Filing Date
2017-04-12
Accepted
2017-04-12 17:16:56
Documents
7
Period of Report
2017-04-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d368841d8k.htm 8-K 32086
2 EX-1.1 d368841dex11.htm EX-1.1 161433
3 EX-4.1 d368841dex41.htm EX-4.1 84318
4 EX-5.1 d368841dex51.htm EX-5.1 12804
5 EX-99.1 d368841dex991.htm EX-99.1 7354
6 EX-99.2 d368841dex992.htm EX-99.2 7356
7 GRAPHIC g368841ex51logo.jpg GRAPHIC 5270
  Complete submission text file 0001193125-17-121519.txt   314007
Mailing Address 3020 CALLAN ROAD SAN DIEGO CA 92121
Business Address 3020 CALLAN ROAD SAN DIEGO CA 92121 8584580900
CYTORI THERAPEUTICS, INC. (Filer) CIK: 0001095981 (see all company filings)

EIN.: 330827593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34375 | Film No.: 17758595
SIC: 3841 Surgical & Medical Instruments & Apparatus